Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate
Open Access
- 25 February 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Urology
- Vol. 29 (4), 503-509
- https://doi.org/10.1007/s00345-011-0659-2
Abstract
To investigate whether narrow band imaging (NBI)-assisted transurethral resection (TUR) (NBI-TUR) has an impact on non-muscle invasive bladder cancer (NMIBC) residual tumour rate compared to white light (WL)-assisted TUR (WL-TUR). Patients with NMIBC treated with either NBI- or WL-TUR were compared in a frequency-matched index-control setting. During NBI-TUR, all suspicious lesions identified by either WL or NBI were resected. Index patients (NBI-TUR, n = 40) were prospectively recruited and control patients (WL-TUR, n = 120) were retrospectively collected, whilst being blinded for their first follow-up (fFU)-status. Non-radical TUR cases, patients without evidence of urothelial carcinoma in the pathology specimen and those with isolated carcinoma in situ or muscle invasive disease were excluded. Matching was based on the risk of tumour recurrence defined by (a) the EORTC risk score for recurrence and (b) the administration or not of one single chemotherapeutic intravesical instillation immediately after TUR. All patients underwent routine follow-up with WL cystoscopy supplemented with cytology at 3 months or re-TUR in selected cases. The residual tumour rates at fFU (RR-fFU) of patients with NMIBC submitted to either NBI- or WL-TUR were compared. Baseline patient and tumour characteristics were comparable between groups. The RR-fFU for WL- and NBI-TUR was 30.5% (36 out of 118 patients) and 15.0% (6 out of 40 patients), respectively (OR: 2.7, one-sided 95% CI: 1.2–6.1; P = 0.03). NBI-TUR decreases residual tumour rate significantly when compared to a matched cohort of WL-TUR.Keywords
This publication has 27 references indexed in Scilit:
- News from Clinical Research Office of the Endourological Society (CROES)Journal of Endourology, 2010
- Narrow‐band imaging cystoscopy to evaluate the response to bacille Calmette‐Guérin therapy: preliminary resultsBJU International, 2010
- Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non‐muscle‐invasive high‐grade bladder cancerBJU International, 2010
- Relook TURBT in superficial bladder cancer: Its importance and its correlation with the tumor ploidyUrologic Oncology, 2009
- Results of Repeated Transurethral Resection for a Second Opinion in Patients Referred for Nonmuscle Invasive Bladder Cancer: The Referral Cancer Center Experience and Review of the LiteratureJournal of Endourology, 2008
- Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high‐grade bladder cancer? A long‐term follow‐up of a randomized studyBJU International, 2007
- The value of a second transurethral resection for T1 bladder cancerBJU International, 2006
- LONG-TERM BENEFIT OF 5-AMINOLEVULINIC ACID FLUORESCENCE ASSISTED TRANSURETHRAL RESECTION OF SUPERFICIAL BLADDER CANCER: 5-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED STUDYJournal of Urology, 2005
- The Health Economics of Bladder CancerPharmacoEconomics, 2003
- Guidelines on Bladder CancerEuropean Urology, 2002